Those strategies might help to make similar public health initiatives work in other cities, suggests the report by Kimberley Roussin Isett, PhD, MPA, of Georgia Institute of Technology, Atlanta, and colleagues. But an accompanying commentary by former New York City Commissioner of Health Pascal James Imperato, MD, MPH&TM, questions whether Mayor Bloomberg's "top down" approach will readily translate elsewhere.
Leadership and Organizational Changes Contributed to Success Dr. Isett and coauthors reviewed public documents and performed interviews to study how Mayor Bloomberg, his staff, and city departments guided their ambitious public health reforms through the "public policy and administration gauntlet." The "theoretically grounded case study approach" focused on two initiatives that were successfully enacted (restrictions on trans fats and policies on clean bus transportation) and one that failed (a tax on sugar-sweetened beverages).
The study focused specifically on lessons for other cities interested in enacting similar public health strategies. The researchers write, "The question is, how feasible is this approach and would it work outside of New York City?"
Their findings suggest that the leadership behind the health initiatives was a multifaceted process. Leadership roles were delegated to administrative officials across city agencies, especially the Board of Health. As one interviewee stated, Mayor Bloomberg "delegated or gave agencies a lot of leeway to do what they felt was right and tried not to dictate."
The City also strategically used "reorganization and coordinative mechanisms" to reach its goals. One key organizational change was the creation of a chronic disease bureau, focusing attention and staff time on the conditions--such obesity and heart and respiratory disease--that were threatening New Yorkers' lives and health.
'NYC Used All the Tools at Its Disposal' That was consistent with a "health in all policies" strategy focusing on the targeted reforms, across City departments and agencies. Contrary to expectations, the researchers found little evidence that incentives were used to drive changes in health behavior or implementation of the reforms. Other key points from the interviews include Mayor Bloomberg's personal commitment to public health, his use of data to drive policy decisions, and his appointment of and reliance on like-minded agency leaders.
"While Mayor Bloomberg often gets credit, the real story here was how NYC used all the tools at its disposal such as City Council passed ordinances, health code resolutions through the Board of Health, and administrative rulemaking," Dr. Isett and coauthors write.
But in his commentary, Dr. Imperato suggests that the study overlooks Mayor Bloomberg's "top down" approach, along with other "core characteristics" that contributed to the success of his initiatives. Dr. Imperato concludes, "The combination of a powerful and wealthy mayor forged in the business world and fiercely dedicated to public health reform and philanthropy, talented and visionary health commissioners, and cost-neutral initiatives is what in the final analysis made public health reform so successful during this period."
Dr. Lloyd F. Novick, Editor of the Journal of Public Health Management and Practice comments, "This case study of public health policy practice during the Bloomberg Administration and the accompanying commentary by Dr. Pascal Imperato--NYC Health Commissioner from 1976 to 1978 and current member of the Advisory Council of the Department of Health and Mental Hygiene in the DeBlasio Administration--are excellent resources for students and others interested in different approaches to public health policy."
INFORMATION:
Click here to read "Learning From New York City: A Case Study of Public Health Policy Practice in the Bloomberg Administration."
Article: "Learning From New York City: A Case Study of Public Health Policy Practice in the Bloomberg Administration." (doi: 10.1097/PHH.0000000000000225)
About Journal of Public Health Management and Practice
Journal of Public Health Management and Practice publishes articles which focus on evidence based public health practice and research. The journal is a bi-monthly peer-reviewed publication guided by a multidisciplinary editorial board of administrators, practitioners and scientists. Journal of Public Health Management and Practice publishes in a wide range of population health topics including research to practice; emergency preparedness; bioterrorism; infectious disease surveillance; environmental health; community health assessment, chronic disease prevention and health promotion, and academic-practice linkages.
About Journal of Public Health Management and Practice
Journal of Public Health Management and Practice publishes articles which focus on evidence based public health practice and research. The journal is a bi-monthly peer-reviewed publication guided by a multidisciplinary editorial board of administrators, practitioners and scientists. Journal of Public Health Management and Practice publishes in a wide range of population health topics including research to practice; emergency preparedness; bioterrorism; infectious disease surveillance; environmental health; community health assessment, chronic disease prevention and health promotion, and academic-practice linkages.
About Wolters Kluwer
Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.
Wolters Kluwer reported 2014 annual revenues of €3.7 billion. The group serves customers in over 170 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on NYSE Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
For more information about our products and organization, visit http://www.wolterskluwer.com, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.
